Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

6.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.5K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

607
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
607
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

6.0K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
6.0K
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

415
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
415
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

895
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
895
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dupilumab treatment restores skin nerve fibre density in patients with moderate-to-severe atopic dermatitis: results from DIFFERENSTAD, an open-label exploratory study.

The British journal of dermatology·2026
Same author

Efficacy and Safety of Nemolizumab at Week 48: Results from the Maintenance Phase of Two Global Phase 3 Pivotal Studies (ARCADIA 1&2) in Patients with Moderate-to-Severe Atopic Dermatitis.

Acta dermato-venereologica·2026
Same author

Quick assessment of quality-of-life in itch: An exploratory validation of the 5-item pruritus life quality.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same author

[Chronic prurigo: overview of pathophysiology, diagnosis, and treatment].

Dermatologie (Heidelberg, Germany)·2026
Same author

Evaluation of itch intensity scales in atopic dermatitis: Differential measurement properties and associations with relevant cytokines.

The Journal of investigative dermatology·2026
Same author

Elevated lymphoma risk in patients with chronic pruritus and chronic prurigo.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Microblading Technique for Tattooing of "Hairstrokes" That Simulate Natural Hair: Eyebrow Tattooing and Correction of Medical Conditions.

Current problems in dermatology·2023
Same journal

Preface.

Current problems in dermatology·2023
Same journal

On the Use, Effectiveness, and Safety of Face Masks, Gloves, and Disinfectants to Prevent Transfer of Microbials between the Tattooist and the Customer: A Practical Review of Pros and Cons Including the Occupational Safety of the Tattooist.

Current problems in dermatology·2023
Same journal

Linearity and Surface Anatomy of the Face: From Embryo to Senescence.

Current problems in dermatology·2023
Same journal

Stretch Mark Treatment by Tattooing and Microneedling.

Current problems in dermatology·2023
Same journal

Auxiliary Utensils in Cosmetic and Medical Tattoo Settings.

Current problems in dermatology·2023
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.6K

Prurigo Nodularis Management.

Athanasios Tsianakas, Claudia Zeidler, Sonja Ständer

    Current Problems in Dermatology
    |September 1, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Prurigo nodularis (PN) causes itchy skin lesions from chronic scratching. Current treatments offer symptomatic relief, but a multimodal approach is best for managing this difficult-to-treat condition.

    More Related Videos

    Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
    03:22

    Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

    Published on: January 27, 2018

    15.8K

    Related Experiment Videos

    Last Updated: Mar 15, 2026

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
    11:39

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

    Published on: July 11, 2013

    39.6K
    Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
    03:22

    Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

    Published on: January 27, 2018

    15.8K

    Area of Science:

    • Dermatology
    • Immunology
    • Neurology

    Background:

    • Prurigo nodularis (PN) is a rare skin disease characterized by intensely itchy, hyperkeratotic papules and nodules.
    • It arises from chronic pruritus and persistent scratching, creating a difficult-to-treat cycle that significantly impacts quality of life.
    • The exact cause of PN is unclear, but immunoneuronal interactions are suspected, with diverse underlying etiologies including dermatological, neurological, psychiatric, and systemic conditions.

    Purpose of the Study:

    • To summarize the clinical presentation, pathogenesis, and current therapeutic strategies for prurigo nodularis.
    • To highlight the challenges in treating PN due to its chronic nature and the itch-scratch cycle.
    • To emphasize the need for multimodal therapeutic approaches.

    Main Methods:

    • Review of existing literature on prurigo nodularis.
    • Analysis of clinical presentations and proposed pathogenetic mechanisms.
    • Compilation of current and emerging treatment options.

    Main Results:

    • PN presents as symmetrically distributed, hyperkeratotic, and intensely itchy lesions.
    • The pathogenesis involves a complex interplay, potentially including immunoneuronal crosstalk, with varied underlying causes.
    • No specific therapy is currently approved, but various symptomatic treatments are employed.

    Conclusions:

    • Prurigo nodularis is a debilitating condition with a complex and heterogeneous etiology.
    • Effective management requires a multimodal therapeutic strategy combining topical and systemic symptomatic treatments.
    • Further research into the pathogenesis is needed to develop targeted therapies.